Preoperative use of Pregabalin: evaluation of the Quality of anesthetic recovery in patients undergoing surgery for the treatment of Breast cancer

Phase 4

Recruiting

• Conditions: Surgical Oncology; Anesthesia Adjuvants; Anesthesia; Breast Neoplasms; N02.421.585.753.750.055

• Registration Number: RBR-4hpxhxh
• Lead Sponsor: Faculdade de Medicina de Jundiaí

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-14
• Last Update Posted: 29 May 2023
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

They will integrate 80 patients aged between 20 and 65 years and physical status ASA I or II, who will undergo elective breast cancer surgeries, performed at the University Hospital of the Faculty of Medicine of Jundiaí (Jundiaí-SP).

Exclusion Criteria

Patient refusal; altered level of consciousness or inability to communicate; presence of any contraindication to the use of any agent described in the project; history of seizure disorder; currently using pregabalin or gabapentin; presence of chronic pain or use of opioids; body mass index (BMI) >40 kg/m2; insulin-dependent diabetes mellitus and renal failure (estimated glomerular filtration rate less than 60 ml/min/1.73 m²); violation of the protocol (such as the use of agents not described in the study protocol); refusal to respond to the questionnaire (QoR-15) in the perioperative period.

Study & Design

• Study Type: Intervention
• Study Design: Not specified